Arvinas Inc
General ticker "ARVN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.7B
Arvinas Inc does not follow the US Stock Market performance with the rate: -24.4%.
Estimated limits based on current volatility of 3.9%: low 17.15$, high 18.54$
Factors to consider:
- Current price 14.0% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [20.93$, 44.66$]
- 2024-12-30 to 2025-12-30 estimated range: [19.51$, 41.42$]
Financial Metrics affecting the ARVN estimates:
- Negative: Non-GAAP EPS, $ of -6.50 <= 0.10
- Negative: Operating profit margin, % of -83.65 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -16.54 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
Short-term ARVN quotes
Long-term ARVN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $53.60MM | $131.40MM | $78.50MM |
| Operating Expenses | $242.00MM | $394.60MM | $480.00MM |
| Operating Income | $-188.40MM | $-263.20MM | $-401.50MM |
| Non-Operating Income | $4.30MM | $12.20MM | $37.60MM |
| R&D Expense | $180.40MM | $315.00MM | $379.70MM |
| Income(Loss) | $-184.10MM | $-251.00MM | $-363.90MM |
| Taxes | $0.00MM | $20.90MM | $0.90MM |
| Other Income(Loss) | $-6.90MM | $-10.60MM | $-2.50MM |
| Profit(Loss) | $-191.00MM | $-282.50MM | $-367.30MM |
| Stockholders Equity | $781.70MM | $564.90MM | $660.00MM |
| Inventory | $4.50MM | $5.50MM | $0.00MM |
| Assets | $1,581.60MM | $1,268.80MM | $1,304.60MM |
| Operating Cash Flow | $559.40MM | $-273.50MM | $-347.80MM |
| Capital expenditure | $4.70MM | $6.80MM | $2.90MM |
| Investing Cash Flow | $-1,313.60MM | $242.80MM | $203.50MM |
| Financing Cash Flow | $278.60MM | $4.70MM | $374.70MM |
| Earnings Per Share* | $-3.66 | $-5.11 | $-6.62 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.